Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. The company is focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/11/24 | $277,000,000 | Series D |
Fidelity International Foresite Capital Samsung Electronics T. Rowe Price Associates Venrock Wellington Management  | undisclosed |
